Shelean Roylance, PA
Physician Assistant · Kailua, HINPI 1932301918
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 38.5% of the total. 2025 is the largest year on record at $678, 2.1 times the $319 reported in 2021.
Across 93 payments — averaging $25.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$906
- Bayer$384
- Lilly USA, LLC$279
- Boehringer Ingelheim$253
- AstraZeneca$180
- Novo Nordisk$147
- plus $207 from 8 others
What the payments were for
- Food & beverage$2,344100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $906 |
| Bayer | 5 | $384 |
| Lilly USA, LLC | 14 | $279 |
| Boehringer Ingelheim | 8 | $253 |
| AstraZeneca(2 entities) | 7 | $180 |
| Novo Nordisk | 9 | $147 |
| Johnson & Johnson | 1 | $85 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Abbott | 1 | $16 |
| Vertex | 1 | $16 |
| Indivior Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,356 in reported general payments places this provider in the 80th percentile of 246 physician assistant providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 61 | $84,622 |
| TrulicityDulaglutide | 37 | $50,617 |
| JanuviaSitagliptin Phosphate | 26 | $34,831 |
| MounjaroTirzepatide | 14 | $22,800 |
| OzempicSemaglutide | 14 | $15,674 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $9,441 |
| Atorvastatin Calcium | 130 | $2,933 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 89 | $2,700 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 98 | $2,676 |
| Pregabalin | 27 | $2,221 |
| Wixela InhubFluticasone Propion/Salmeterol | 18 | $1,541 |
| Pioglitazone Hcl | 12 | $1,315 |
| Metformin Hcl ErMetformin Hcl | 48 | $865 |
| Gabapentin | 52 | $747 |
| Losartan Potassium | 44 | $735 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $253 | $84,62261 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $279 | $73,41851 claims |
| Novo NordiskOzempic | $147 | $15,67414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 246 physician assistant providers in Hawaii.
Other physician assistant in Kailua
- Shane MillardKailua$3K
- Christopher RazonableKailua$1K
- Brooke GarciaMililani$381K
- Eric YukumotoHonolulu$41K
- Dorothy MauriceHonolulu$39K
- Patricia AchayKailua Kona$22K
- Marne Carmichael WalshHilo$17K
- Edie HamiltonKahului$13K
- Joycelyn ChunHonolulu$11K
- Rachel InouyeHonolulu$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.